Multiple endocrine neoplasia type 1 risk factors: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Mahshid)
No edit summary
 
Line 8: Line 8:
==Risk Factors==
==Risk Factors==
Common risk factors in the development of [[Multiple endocrine neoplasia type 1|multiple endocrine neoplasia type-1]] include: <ref name="pmid22581216">{{cite journal| author=de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML et al.| title=Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. | journal=Eur J Endocrinol | year= 2012 | volume= 167 | issue= 2 | pages= 181-7 | pmid=22581216 | doi=10.1530/EJE-12-0210 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22581216  }} </ref>
Common risk factors in the development of [[Multiple endocrine neoplasia type 1|multiple endocrine neoplasia type-1]] include: <ref name="pmid22581216">{{cite journal| author=de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML et al.| title=Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. | journal=Eur J Endocrinol | year= 2012 | volume= 167 | issue= 2 | pages= 181-7 | pmid=22581216 | doi=10.1530/EJE-12-0210 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22581216  }} </ref>
:* Positive [[family history]] <ref name="pmid28736585">{{cite journal| author=Kaiwar C, Macklin SK, Gass JM, Jackson J, Klee EW, Hines SL et al.| title=Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1. | journal=Hered Cancer Clin Pract | year= 2017 | volume= 15 | issue=  | pages= 10 | pmid=28736585 | doi=10.1186/s13053-017-0070-0 | pmc=5521080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28736585  }} </ref>
:* Positive [[family history]] <ref name="pmid28736585">{{cite journal| author=Kaiwar C, Macklin SK, Gass JM, Jackson J, Klee EW, Hines SL et al.| title=Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1. | journal=Hered Cancer Clin Pract | year= 2017 | volume= 15 | issue=  | pages= 10 | pmid=28736585 | doi=10.1186/s13053-017-0070-0 | pmc=5521080 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28736585  }} </ref>
:* History of [[Zollinger-Ellison syndrome]] <ref name="pmid14747767">{{cite journal| author=Gibril F, Schumann M, Pace A, Jensen RT| title=Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. | journal=Medicine (Baltimore) | year= 2004 | volume= 83 | issue= 1 | pages= 43-83 | pmid=14747767 | doi=10.1097/01.md.0000112297.72510.32 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14747767  }} </ref> <ref name="pmid23877214">{{cite journal| author=Lee NE, Lee YJ, Yun SH, Lee JU, Park MS, Kim JK et al.| title=A case of Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1 with urolithiasis as the initial presentation. | journal=Korean J Gastroenterol | year= 2013 | volume= 61 | issue= 6 | pages= 333-7 | pmid=23877214 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23877214  }} </ref>
:* History of [[Zollinger-Ellison syndrome]] <ref name="pmid14747767">{{cite journal| author=Gibril F, Schumann M, Pace A, Jensen RT| title=Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. | journal=Medicine (Baltimore) | year= 2004 | volume= 83 | issue= 1 | pages= 43-83 | pmid=14747767 | doi=10.1097/01.md.0000112297.72510.32 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14747767  }} </ref><ref name="pmid23877214">{{cite journal| author=Lee NE, Lee YJ, Yun SH, Lee JU, Park MS, Kim JK et al.| title=A case of Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1 with urolithiasis as the initial presentation. | journal=Korean J Gastroenterol | year= 2013 | volume= 61 | issue= 6 | pages= 333-7 | pmid=23877214 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23877214  }} </ref>
:* [[Pituitary disease|Pituitary dysfunction]] <ref name="pmid28458907">{{cite journal| author=Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T et al.| title=Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy. | journal=Endocrinol Diabetes Metab Case Rep | year= 2017 | volume= 2017 | issue=  | pages=  | pmid=28458907 | doi=10.1530/EDM-17-0027 | pmc=5404709 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28458907  }} </ref> <ref name="pmid5404709">{{cite journal| author=Bonenti G, Corsino G| title=[Serum betalysine in dystrophic subjects]. | journal=Minerva Pediatr | year= 1969 | volume= 21 | issue= 34 | pages= 1557-60 | pmid=5404709 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5404709  }} </ref>
:* [[Pituitary disease|Pituitary dysfunction]] <ref name="pmid28458907">{{cite journal| author=Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T et al.| title=Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy. | journal=Endocrinol Diabetes Metab Case Rep | year= 2017 | volume= 2017 | issue=  | pages=  | pmid=28458907 | doi=10.1530/EDM-17-0027 | pmc=5404709 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28458907  }} </ref><ref name="pmid5404709">{{cite journal| author=Bonenti G, Corsino G| title=[Serum betalysine in dystrophic subjects]. | journal=Minerva Pediatr | year= 1969 | volume= 21 | issue= 34 | pages= 1557-60 | pmid=5404709 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5404709  }} </ref>


==References==
==References==

Latest revision as of 12:05, 12 August 2019

Multiple endocrine neoplasia type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple endocrine neoplasia type 1 risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 1 risk factors

CDC on Multiple endocrine neoplasia type 1 risk factors

Multiple endocrine neoplasia type 1 risk factors in the news

Blogs on Multiple endocrine neoplasia type 1 risk factors

Directions to Hospitals Treating Multiple endocrine neoplasia type 1

Risk calculators and risk factors for Multiple endocrine neoplasia type 1 risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Common risk factors in the development of multiple endocrine neoplasia type-1 are family history, history of Zollinger-Ellison syndrome and pituitary dysfunction.

Risk Factors

Common risk factors in the development of multiple endocrine neoplasia type-1 include: [1]

References

  1. ↑ de Laat JM, Tham E, Pieterman CR, Vriens MR, Dorresteijn JA, Bots ML; et al. (2012). "Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors". Eur J Endocrinol. 167 (2): 181–7. doi:10.1530/EJE-12-0210. PMID 22581216.
  2. ↑ Kaiwar C, Macklin SK, Gass JM, Jackson J, Klee EW, Hines SL; et al. (2017). "Late onset asymptomatic pancreatic neuroendocrine tumor - A case report on the phenotypic expansion for MEN1". Hered Cancer Clin Pract. 15: 10. doi:10.1186/s13053-017-0070-0. PMC 5521080. PMID 28736585.
  3. ↑ Gibril F, Schumann M, Pace A, Jensen RT (2004). "Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature". Medicine (Baltimore). 83 (1): 43–83. doi:10.1097/01.md.0000112297.72510.32. PMID 14747767.
  4. ↑ Lee NE, Lee YJ, Yun SH, Lee JU, Park MS, Kim JK; et al. (2013). "A case of Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1 with urolithiasis as the initial presentation". Korean J Gastroenterol. 61 (6): 333–7. PMID 23877214.
  5. ↑ Uraki S, Ariyasu H, Doi A, Furuta H, Nishi M, Usui T; et al. (2017). "Hypersecretion of ACTH and PRL from pituitary adenoma in MEN1, adequately managed by medical therapy". Endocrinol Diabetes Metab Case Rep. 2017. doi:10.1530/EDM-17-0027. PMC 5404709. PMID 28458907.
  6. ↑ Bonenti G, Corsino G (1969). "[Serum betalysine in dystrophic subjects]". Minerva Pediatr. 21 (34): 1557–60. PMID 5404709.

Template:WS Template:WH

Retrieved from "https://www.wikidoc.org/index.php?title=Multiple_endocrine_neoplasia_type_1_risk_factors&oldid=1578984"